FFCP PHASE2:Hg19::chr16:88858526..88858538,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p@chr16:88858526..88858538, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr16:88858526..88858538, - |
Coexpression cluster: | C266_acute_chronic_leukemia_small_choriocarcinoma_hepatoma_Mast |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr16:88858526..88858538- |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
CD34-positive, CD38-negative hematopoietic stem cell | 9.73e-13 | 1 |
skin fibroblast | 2.01e-08 | 23 |
Showing 1 to 2 of 2 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 2.96e-14 | 39 |
myeloid leukemia | 2.36e-13 | 31 |
hematologic cancer | 9.29e-11 | 51 |
immune system cancer | 9.29e-11 | 51 |
musculoskeletal system disease | 1.47e-10 | 5 |
myotonic disease | 1.47e-10 | 5 |
muscle tissue disease | 1.47e-10 | 5 |
myopathy | 1.47e-10 | 5 |
muscular disease | 1.47e-10 | 5 |
myotonic dystrophy | 1.47e-10 | 5 |
Showing 1 to 10 of 10 entries